Submitted recommendations
Submitted recommendations
The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV of REACH (the "Authorisation List") and for these substances proposes Annex XIV entries (i.e. transitional arrangements and, where relevant, exemptions and review periods) to the European Commission, taking into account the opinion of the Member State Committee. The European Commission finally decides, by "comitology" procedure (with scrutiny), which substances will be included in Annex XIV and what the associated entries will be.
The below table includes all substances that have been included in ECHA's draft or final recommendations for inclusion of Candidate List substances in Annex XIV. The "Status"- column indicates whether the substances have been recommended for inclusion or are already included in Annex XIV. Documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.
Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
Submitted recommendations
- 9th Annex XIV recommendation 1 October 2019 [PDF][EN]
- Amendment recommendation 10 July 2019 [PDF][EN]
- 8th Annex XIV recommendation 5 February 2018 [PDF][EN]
- 7th Annex XIV recommendation 10 November 2016 [PDF][EN]
- 6th Annex XIV recommendation 1 July 2015 [PDF][EN]
- 5th Annex XIV recommendation 6 February 2014 [PDF][EN]
- 4th Annex XIV recommendation 17 January 2013 [PDF][EN]
- 3rd Annex XIV recommendation 20 December 2011 [PDF][EN]
- 2nd Annex XIV recommendation 17 December 2010 [PDF][EN]
- 1st Annex XIV recommendation 1 June 2009 [PDF][EN]
| Formaldehyde, oligomeric reaction products with aniline (technical MDA) | 500-036-1 | 25214-70-4 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| Fatty acids, C16-18, lead salts | 292-966-7 | 91031-62-8 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Anthracene oil | 292-602-7 | 90640-80-5 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| Alkanes, C10-13, chloro (Short Chain Chlorinated Paraffins) | 287-476-5 | 85535-84-8 | 1 (2009) | Recommended for inclusion in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, dipentylester, branched and linear | 284-032-2 | 84777-06-0 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, di-C6-8-branched alkyl esters, C7-rich | 276-158-1 | 71888-89-6 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| [Phthalato(2-)]dioxotrilead | 273-688-5 | 69011-06-9 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 1,2-benzenedicarboxylic acid, di-C6-10-alkyl esters; 1,2-benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5) |
271-094-0 272-013-1 | 68515-51-5 68648-93-1 | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear | 271-093-5 | 68515-50-4 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| 1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters | 271-084-6 | 68515-42-4 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| Pitch, coal tar, high temp. | 266-028-2 | 65996-93-2 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| Sulfurous acid, lead salt, dibasic | 263-467-1 | 62229-08-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Acetic acid, lead salt, basic | 257-175-3 | 51404-69-4 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Pentazinc chromate octahydroxide | 256-418-0 | 49663-84-5 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| 2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6-(sec-butyl)phenol (UV-350) | 253-037-1 | 36437-37-3 | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| 2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328) | 247-384-8 | 25973-55-1 | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| Hexabromocyclododecane (HBCDD) and all major diastereoisomers identified: Alpha-hexabromocyclododecane Beta-hexabromocyclododecane Gamma-hexabromocyclododecane |
247-148-4 221-695-9 | 25637-99-4 3194-55-6 134237-50-6 134237-51-7 134237-52-8 | 1 (2009) | Included in Annex XIV | |
| Hexahydromethylphthalic anhydride [1], Hexahydro-4-methylphthalic anhydride [2], Hexahydro-1-methylphthalic anhydride [3], Hexahydro-3-methylphthalic anhydride [4] [The individual isomers [2], [3] and [4] (including their cis- and trans- stereo isomeric forms) and all possible combinations of the isomers [1] are covered by this entry] |
247-094-1 243-072-0 256-356-4 260-566-1 | 25550-51-0 19438-60-9 48122-14-1 57110-29-9 | 7 (draft: November 2015; final: November 2016) | Not recommended in this round | |
| Hexahydromethylphthalic anhydride [1], Hexahydro-4-methylphthalic anhydride [2], Hexahydro-1-methylphthalic anhydride [3], Hexahydro-3-methylphthalic anhydride [4] [The individual isomers [2], [3] and [4] (including their cis- and trans- stereo isomeric forms) and all possible combinations of the isomers [1] are covered by this entry] |
247-094-1 243-072-0 256-356-4 260-566-1 | 25550-51-0 19438-60-9 48122-14-1 57110-29-9 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Trixylyl phosphate | 246-677-8 | 25155-23-1 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Dichromium tris(chromate) | 246-356-2 | 24613-89-6 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (DOTE) | 239-622-4 | 15571-58-1 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Sodium perborate; perboric acid, sodium salt |
239-172-9 234-390-0 | - | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Lead chromate molybdate sulphate red (C.I. Pigment Red 104) | 235-759-9 | 12656-85-8 | 2 (2010) | Included in Annex XIV | |
| Dioxobis(stearato)trilead | 235-702-8 | 12578-12-0 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Tetraboron disodium heptaoxide, hydrate | 235-541-3 | 12267-73-1 | 6 (draft: September 2014; final: July 2015) | Recommended for inclusion in Annex XIV | |
| Tetralead trioxide sulphate | 235-380-9 | 12202-17-4 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Tetralead trioxide sulphate | 235-380-9 | 12202-17-4 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Trilead dioxide phosphonate | 235-252-2 | 12141-20-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Pentalead tetraoxide sulphate | 235-067-7 | 12065-90-6 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Pentalead tetraoxide sulphate | 235-067-7 | 12065-90-6 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Lead oxide sulfate | 234-853-7 | 12036-76-9 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Silicic acid, lead salt | 234-363-3 | 11120-22-2 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Potassium hydroxyoctaoxodizincatedichromate | 234-329-8 | 11103-86-9 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| Sodium dichromate | 234-190-3 |
7789-12-0 10588-01-9 | 3 (2011) | Included in Annex XIV | |
| Cobalt(II) dinitrate | 233-402-1 | 10141-05-6 | 3 (2011) | Recommended for inclusion in Annex XIV | |
| Cobalt(II) sulphate | 233-334-2 | 10124-43-3 | 3 (2011) | Recommended for inclusion in Annex XIV | |
| Boric acid |
233-139-2 234-343-4 | 10043-35-3 11113-50-1 | 6 (draft: September 2014; final: July 2015) | Recommended for inclusion in Annex XIV | |
| Pyrochlore, antimony lead yellow | 232-382-1 | 8012-00-8 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Ammonium dichromate | 232-143-1 | 7789-09-5 | 3 (2011) | Included in Annex XIV | |
| Strontium chromate | 232-142-6 | 7789-06-2 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| Potassium chromate | 232-140-5 | 7789-00-6 | 3 (2011) | Included in Annex XIV | |
| Potassium dichromate | 231-906-6 | 7778-50-9 | 3 (2011) | Included in Annex XIV | |
| Arsenic acid | 231-901-9 | 7778-39-4 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| Sodium chromate | 231-889-5 | 7775-11-3 | 3 (2011) | Included in Annex XIV | |
| Lead chromate | 231-846-0 | 7758-97-6 | 2 (2010) | Included in Annex XIV | |
| Acids generated from chromium trioxide and their oligomers. Names of the acids and their oligomers: Chromic acid, Dichromic acid, Oligomers of chromic acid and dichromic acid. |
231-801-5 236-881-5 | 7738-94-5 13530-68-2 | 3 (2011) | Included in Annex XIV | |
| Cobalt dichloride | 231-589-4 | 7646-79-9 | 3 (2011) | Recommended for inclusion in Annex XIV | |
| Sodium peroxometaborate | 231-556-4 | 7632-04-4 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| 2,4-di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol (UV-327) | 223-383-8 | 3864-99-1 | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| 2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV-320) | 223-346-6 | 3846-71-7 | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| Lead sulfochromate yellow (C.I. Pigment Yellow 34) | 215-693-7 | 1344-37-2 | 2 (2010) | Included in Annex XIV | |
| Chromium trioxide | 215-607-8 | 1333-82-0 | 3 (2011) | Included in Annex XIV | |
| Disodium tetraborate, anhydrous | 215-540-4 |
1330-43-4 1303-96-4 12179-04-3 | 6 (draft: September 2014; final: July 2015) | Recommended for inclusion in Annex XIV | |
| Diarsenic trioxide | 215-481-4 | 1327-53-3 | 2 (2010) | Included in Annex XIV | |
| Trilead bis(carbonate) dihydroxide | 215-290-6 | 1319-46-6 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Lead monoxide (lead oxide) | 215-267-0 | 1317-36-8 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Lead monoxide (lead oxide) | 215-267-0 | 1317-36-8 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Orange lead (lead tetroxide) | 215-235-6 | 1314-41-6 | 6 (draft: September 2014; final: July 2015) | Not recommended in this round | |
| Orange lead (lead tetroxide) | 215-235-6 | 1314-41-6 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Diboron trioxide | 215-125-8 | 1303-86-2 | 6 (draft: September 2014; final: July 2015) | Recommended for inclusion in Annex XIV | |
| Diarsenic pentaoxide | 215-116-9 | 1303-28-2 | 2 (2010) | Included in Annex XIV | |
| Bis(pentabromophenyl) ether (decabromodiphenyl ether) (DecaBDE) | 214-604-9 | 1163-19-5 | 5 (draft: 2013; final: February 2014) | Not recommended in this round | |
| 1-Methyl-2-pyrrolidone (NMP) | 212-828-1 | 872-50-4 | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| Diisopentylphthalate | 210-088-4 | 605-50-5 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 4,4'-bis(dimethylamino)-4''-(methylamino)trityl alcohol with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2) | 209-218-2 | 561-41-1 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Cobalt(II) carbonate | 208-169-4 | 513-79-1 | 3 (2011) | Recommended for inclusion in Annex XIV | |
| Dipentyl phthalate (DPP) | 205-017-9 | 131-18-0 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| N,N-Dimethylacetamide (DMAC) | 204-826-4 | 127-19-5 | 4 (draft: 2012; final: January 2013) | Recommended for inclusion in Annex XIV | |
| Diazene-1,2-dicarboxamide (C,C`-azodi(formamide)) (ADCA) | 204-650-8 | 123-77-3 | 5 (draft: 2013; final: February 2014) | Recommended for inclusion in Annex XIV | |
| 2,4 – Dinitrotoluene (2,4-DNT) | 204-450-0 | 121-14-2 | 2 (2010) | Included in Annex XIV | |
| Bis(2-methoxyethyl) phthalate | 204-212-6 | 117-82-8 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| Bis(2-ethylhexyl) phthalate (DEHP) | 204-211-0 | 117-81-7 | 1 (2009), amendment recommendation (2019) | Included in Annex XIV | |
| Tris(2-chloroethyl)phosphate (TCEP) | 204-118-5 | 115-96-8 | 2 (2010) | Included in Annex XIV | |
| Bis(2-methoxyethyl) ether (Diglyme) | 203-924-4 | 111-96-6 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| 2-ethoxyethanol | 203-804-1 | 110-80-5 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 2-methoxyethanol | 203-713-7 | 109-86-4 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 1,2-Dichloroethane (EDC) | 203-458-1 | 107-06-2 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| 1-bromopropane (n-propyl bromide) | 203-445-0 | 106-94-5 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 4,4’- Diaminodiphenylmethane (MDA) | 202-974-4 | 101-77-9 | 1 (2009) | Included in Annex XIV | |
| 2,2'-dichloro-4,4'-methylenedianiline (MOCA) | 202-918-9 | 101-14-4 | 4 (draft: 2012; final: January 2013) | Included in Annex XIV | |
| Benzyl butyl phthalate (BBP) | 201-622-7 | 85-68-7 | 1 (2009), amendment recommendation (2019) | Included in Annex XIV | |
| Cyclohexane-1,2-dicarboxylic anhydride [1], cis-cyclohexane-1,2-dicarboxylic anhydride [2], trans-cyclohexane-1,2-dicarboxylic anhydride [3] [The individual cis- [2] and trans- [3] isomer substances and all possible combinations of the cis- and trans-isomers [1] are covered by this entry] |
201-604-9 236-086-3 238-009-9 | 85-42-7 13149-00-3 14166-21-3 | 7 (draft: November 2015; final: November 2016) | Not recommended in this round | |
| Cyclohexane-1,2-dicarboxylic anhydride [1], cis-cyclohexane-1,2-dicarboxylic anhydride [2], trans-cyclohexane-1,2-dicarboxylic anhydride [3] [The individual cis- [2] and trans- [3] isomer substances and all possible combinations of the cis- and trans-isomers [1] are covered by this entry] |
201-604-9 236-086-3 238-009-9 | 85-42-7 13149-00-3 14166-21-3 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Dihexyl phthalate | 201-559-5 | 84-75-3 | 7 (draft: November 2015; final: November 2016) | Recommended for inclusion in Annex XIV | |
| Dibutyl phthalate (DBP) | 201-557-4 | 84-74-2 | 1 (2009), amendment recommendation (2019) | Included in Annex XIV | |
| Diisobutyl phthalate (DIBP) | 201-553-2 | 84-69-5 | 2 (2010), amendment recommendation (2019) | Included in Annex XIV | |
| 5-tert-butyl-2,4,6-trinitro-m-xylene (Musk xylene) | 201-329-4 | 81-15-2 | 1 (2009) | Included in Annex XIV | |
| 4,4'-isopropylidenediphenol (bisphenol A; BPA) | 201-245-8 | 80-05-7 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Trichloroethylene | 201-167-4 | 79-01-6 | 3 (2011) | Included in Annex XIV | |
| Tetraethyllead | 201-075-4 | 78-00-2 | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| Cobalt(II) diacetate | 200-755-8 | 71-48-7 | 3 (2011) | Recommended for inclusion in Annex XIV | |
| N,N-dimethylformamide (DMF) | 200-679-5 | 68-12-2 | 5 (draft: 2013; final: February 2014) | Recommended for inclusion in Annex XIV | |
| 1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™) | - | - | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
| 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated [covering well-defined substances and UVCB substances, polymers and homologues] | - | - | 5 (draft: 2013; final: February 2014) | Included in Annex XIV | |
| 4-Nonylphenol, branched and linear, ethoxylated [substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof] | - | - | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [1], 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [2] [covering any of the individual stereoisomers of [1] and [2] or any combination thereof] (karanal group) | - | - | 8 (draft: March 2017; final: February 2018) | Recommended for inclusion in Annex XIV | |
| Aluminosilicate Refractory Ceramic Fibres (Al-RCF) are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium and silicon are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm) c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight | - | - | 5 (draft: 2013; final: February 2014) | Recommended for inclusion in Annex XIV | |
| N-pentyl-isopentylphthalate | - | 776297-69-9 | 6 (draft: September 2014; final: July 2015) | Included in Annex XIV | |
| Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (reaction mass of DOTE and MOTE) | - | - | 9 (draft: September 2018; final: October 2019) | Recommended for inclusion in Annex XIV | |
Categories Display
Tagged as:
(click the tag to search for relevant content)
Route: .live2
